Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
暂无分享，去创建一个
M. Kreissl | M. Schlumberger | M. Brose | B. Nelkin | D. Ball | L. Licitra | P. Schöffski | S. Sherman | R. Elisei | S. Müller | M. Shah | B. Niederle | L. Wirth | H. Ali | Y. Yaron | E. Cohen | J. Krajewska | D. Clary | M. Mangeshkar | M. Brose | Manisha H. Shah | Lori J. Wirth | Haythem Y. Ali | Bruno Niederle | Martin Schlumberger | Stefan Müller | Lisa Licitra | Jolanta Krajewska | Michael C. Kreissl | Bruno Niederle | Douglas O. Clary | E. Cohen | L. Licitra | J.A. Krajewska